UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 161

Sortiert nach

Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune-Mediated Inflammatory Diseases

Honghui Zhou, Diane R. Mould

First edition., 2019

Link zum Volltext

Verfügbarkeit prüfen

Patient factors that increase infliximab clearance and shorten half-life in inflammatory bowel disease: a population pharmacokinetic study

Inflammatory bowel diseases, 2014-12, Vol.20 (12), p.2247-2259

2014

Link zum Volltext

Verfügbarkeit prüfen

"Getting the Dose Right"-Revisiting the Topic With Focus on Biologic Agents

Clinical pharmacology and therapeutics, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacokinetics-Based Dosing Paradigms

Clinical pharmacology and therapeutics, 2012-04, Vol.91 (4), p.635-646

2012

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetic Analysis of Voriconazole and Anidulafungin in Adult Patients with Invasive Aspergillosis

Antimicrobial agents and chemotherapy, 2014-08, Vol.58 (8), p.4718-4726

2014

Link zum Volltext

Verfügbarkeit prüfen

Development and Implementation of Electronic Health Record–Integrated Model‐Informed Clinical Decision Support Tools for the Precision Dosing of Drugs

Clinical pharmacology and therapeutics, 2020-01, Vol.107 (1), p.129-135

2020

Link zum Volltext

Verfügbarkeit prüfen

Drug Development of Therapeutic Monoclonal Antibodies

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2016-08, Vol.30 (4), p.275-293

2016

Link zum Volltext

Verfügbarkeit prüfen

Population PK and Exposure–Response Relationships for the Antibody–Drug Conjugate Brentuximab Vedotin in CTCL Patients in the Phase III ALCANZA Study

Clinical pharmacology and therapeutics, 2018-11, Vol.104 (5), p.989-999

2018

Link zum Volltext

Verfügbarkeit prüfen

Dashboard-Driven Accelerated Infliximab Induction Dosing Increases Infliximab Durability and Reduces Immunogenicity

Inflammatory bowel diseases, 2022-09, Vol.28 (9), p.1375-1385

2022

Link zum Volltext

Verfügbarkeit prüfen

Accelerated Clearance of Infliximab is Associated With Treatment Failure in Patients With Corticosteroid-Refractory Acute Ulcerative Colitis

Journal of Crohn's and colitis, 2018-05, Vol.12 (6), p.662-669

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies: Concepts and Lessons for Drug Development

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2010-02, Vol.24 (1), p.23-39

2010

Link zum Volltext

Verfügbarkeit prüfen

The Pharmacokinetics of Biologics: A Primer

Digestive diseases (Basel), 2015-01, Vol.33 (1), p.61-69

Mould, Diane R.

2015

Link zum Volltext

Verfügbarkeit prüfen

Increased Induction Infliximab Clearance Predicts Early Antidrug Antibody Detection

Journal of clinical pharmacology, 2021-02, Vol.61 (2), p.224-233

2021

Link zum Volltext

Verfügbarkeit prüfen

Vedolizumab for the treatment of active ulcerative colitis: A randomized controlled phase 2 dose‐ranging study

Inflammatory bowel diseases, 2012-08, Vol.18 (8), p.1470-1479

2012

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic Dashboard-Recommended Dosing Is Different than Standard of Care Dosing in Infliximab-Treated Pediatric IBD Patients

The AAPS journal, 2017-01, Vol.19 (1), p.215-222

2017

Link zum Volltext

Verfügbarkeit prüfen

Personalized Dosing of Infliximab in Patients With Inflammatory Bowel Disease Using a Bayesian Approach: A Next Step in Therapeutic Drug Monitoring

Journal of clinical pharmacology, 2023-04, Vol.63 (4), p.480-489

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparative Analysis of Posiphen Pharmacokinetics across Different Species-Similar Absorption and Metabolism in Mouse, Rat, Dog and Human

Biomolecules (Basel, Switzerland), 2024-05, Vol.14 (5), p.582

2024

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Individual Serum Infliximab Concentrations in Inflammatory Bowel Disease by a Bayesian Dashboard System

Journal of clinical pharmacology, 2018-06, Vol.58 (6), p.790-802

2018

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetics of Brentuximab Vedotin in Adult and Pediatric Patients With Relapsed/Refractory Hematologic Malignancies: Model‐Informed Hypothesis Generation for Pediatric Dosing Regimens

Journal of clinical pharmacology, 2020-12, Vol.60 (12), p.1585-1597

2020

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetic-Pharmacodynamic Analysis of Voriconazole and Anidulafungin in Adult Patients with Invasive Aspergillosis

Antimicrobial agents and chemotherapy, 2014-08, Vol.58 (8), p.4727-4736

2014

Link zum Volltext

Verfügbarkeit prüfen

Dashboard systems: Pharmacokinetic/pharmacodynamic mediated dose optimization for monoclonal antibodies

Journal of clinical pharmacology, 2015-03, Vol.55 (S3), p.S51-S59

2015

Link zum Volltext

Verfügbarkeit prüfen

Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis

Clinical pharmacokinetics, 2021-05, Vol.60 (5), p.665-676

2021

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetic Modeling of Mogamulizumab in Adults With Cutaneous T‐Cell Lymphoma or Adult T‐Cell Lymphoma

Journal of clinical pharmacology, 2020-01, Vol.60 (1), p.58-66

2020

Link zum Volltext

Verfügbarkeit prüfen

Accounting for Pharmacokinetic Variability of Certolizumab Pegol in Patients with Crohn’s Disease

Clinical pharmacokinetics, 2017-12, Vol.56 (12), p.1513-1523

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of dashboard driven dosing of infliximab in inflammatory bowel disease patients; a randomized controlled trial

Scandinavian journal of gastroenterology, 2021-02, Vol.56 (2), p.145-154

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 161

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(130)

Publikationsform

Sprache

Englisch
(161)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune-Mediated Inflammatory Diseases

Patient factors that increase infliximab clearance and shorten half-life in inflammatory bowel disease: a population pharmacokinetic study

"Getting the Dose Right"-Revisiting the Topic With Focus on Biologic Agents

Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacokinetics-Based Dosing Paradigms

Population Pharmacokinetic Analysis of Voriconazole and Anidulafungin in Adult Patients with Invasive Aspergillosis

Development and Implementation of Electronic Health Record–Integrated Model‐Informed Clinical Decision Support Tools for the Precision Dosing of Drugs

Drug Development of Therapeutic Monoclonal Antibodies

Population PK and Exposure–Response Relationships for the Antibody–Drug Conjugate Brentuximab Vedotin in CTCL Patients in the Phase III ALCANZA Study

Dashboard-Driven Accelerated Infliximab Induction Dosing Increases Infliximab Durability and Reduces Immunogenicity

Accelerated Clearance of Infliximab is Associated With Treatment Failure in Patients With Corticosteroid-Refractory Acute Ulcerative Colitis

Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies: Concepts and Lessons for Drug Development

The Pharmacokinetics of Biologics: A Primer

Increased Induction Infliximab Clearance Predicts Early Antidrug Antibody Detection

Vedolizumab for the treatment of active ulcerative colitis: A randomized controlled phase 2 dose‐ranging study

Pharmacokinetic Dashboard-Recommended Dosing Is Different than Standard of Care Dosing in Infliximab-Treated Pediatric IBD Patients

Personalized Dosing of Infliximab in Patients With Inflammatory Bowel Disease Using a Bayesian Approach: A Next Step in Therapeutic Drug Monitoring

Comparative Analysis of Posiphen Pharmacokinetics across Different Species-Similar Absorption and Metabolism in Mouse, Rat, Dog and Human

Prediction of Individual Serum Infliximab Concentrations in Inflammatory Bowel Disease by a Bayesian Dashboard System

Population Pharmacokinetics of Brentuximab Vedotin in Adult and Pediatric Patients With Relapsed/Refractory Hematologic Malignancies: Model‐Informed Hypothesis Generation for Pediatric Dosing Regimens

Population Pharmacokinetic-Pharmacodynamic Analysis of Voriconazole and Anidulafungin in Adult Patients with Invasive Aspergillosis

Dashboard systems: Pharmacokinetic/pharmacodynamic mediated dose optimization for monoclonal antibodies

Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis

Population Pharmacokinetic Modeling of Mogamulizumab in Adults With Cutaneous T‐Cell Lymphoma or Adult T‐Cell Lymphoma

Accounting for Pharmacokinetic Variability of Certolizumab Pegol in Patients with Crohn’s Disease

Efficacy of dashboard driven dosing of infliximab in inflammatory bowel disease patients; a randomized controlled trial

Suchergebnisse filtern